|
Systemic Sclerosis
Citations 121-130 of 242 total displayed.
|
Past content
(since Jan 2001):
|
- BASIC SCIENCE
Angiotensin-converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosis
- F. Bartoli, C. Angotti, C. Fatini, M. L. Conforti, S. Guiducci, J. Blagojevic, D. Melchiorre, G. Fiori, S. Generini, N. Damjanov, S. Rednic, A. Pignone, S. Castellani, R. Abbate, and M. Matucci Cerinic
Rheumatology 2007; 46: 772-775.
[Abstract]
[Full Text]
- BASIC SCIENCE
Autoantibody against peroxiredoxin I, an antioxidant enzyme, in patients with systemic sclerosis: possible association with oxidative stress
- Y. Iwata, F. Ogawa, K. Komura, E. Muroi, T. Hara, K. Shimizu, M. Hasegawa, M. Fujimoto, Y. Tomita, and S. Sato
Rheumatology 2007; 46: 790-795.
[Abstract]
[Full Text]
- CLINICAL
Skin involvement in scleroderma—where histological and clinical scores meet
- F. Verrecchia, J. Laboureau, O. Verola, N. Roos, R. Porcher, P. Bruneval, M. Ertault, K. Tiev, L. Michel, A. Mauviel, and D. Farge
Rheumatology 2007; 46: 833-841.
[Abstract]
[Full Text]
- CLINICAL
A new computerized method for the assessment of skin lesions in localized scleroderma
- F. Zulian, D. Meneghesso, E. Grisan, F. Vittadello, A. Belloni Fortina, B. Pigozzi, A. C. Frigo, G. Martini, and A. Ruggeri
Rheumatology 2007; 46: 856-860.
[Abstract]
[Full Text]
- CLINICAL
Appearance self-esteem in systemic sclerosis—subjective experience of skin deformity and its relationship with physician-assessed skin involvement, disease status and psychological variables
- W. G. J. M. van Lankveld, M. C. Vonk, H. Teunissen, and F. H. J. van den Hoogen
Rheumatology 2007; 46: 872-876.
[Abstract]
[Full Text]
- MATTERS ARISING
SF-36 Scales in the Relaxin study
- D. Khanna, G. S. Park, and J. Seibold
Rheumatology 2007; 46: 724.
[Extract]
[Full Text]
- EDITORIALS
Microchimeric cells: guardians or actors of immunity in scleroderma?
- N. C. Lambert
Rheumatology 2007; 46: 382-383.
[Extract]
[Full Text]
- BASIC SCIENCE
Circulating levels of N -(carboxymethyl)lysine are increased in systemic sclerosis
- O. Kaloudi, G. Basta, F. Perfetto, F. Bartoli, A. Del Rosso, I. Miniati, M. L. Conforti, S. Generini, S. Guiducci, R. Abbate, A. Pignone, S. Castellani, R. Livi, R. De Caterina, and M. Matucci-Cerinic
Rheumatology 2007; 46: 412-416.
[Abstract]
[Full Text]
- CLINICAL
Mycophenolate mofetil in diffuse cutaneous systemic sclerosis—a retrospective analysis
- S. I. Nihtyanova, G. M. Brough, C. M. Black, and C. P. Denton
Rheumatology 2007; 46: 442-445.
[Abstract]
[Full Text]
- CLINICAL
The ‘distal–dorsal difference’: a thermographic parameter by which to differentiate between primary and secondary Raynaud's phenomenon
- M. E. Anderson, T. L. Moore, M. Lunt, and A. L. Herrick
Rheumatology 2007; 46: 533-538.
[Abstract]
[Full Text]
|
|
